Clinical trial
Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal…
NCT00159484 · University of Southern California, Other · Unknown status
Key facts
| NCT number | NCT00159484 |
|---|---|
| Title | Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer |
| Official title | Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer (CEPO906AUS10) |
| Lead sponsor | University of Southern California, Other |
| Collaborators | Novartis Industry |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Colon Cancer, Colorectal Cancer |
| Intervention type | Drug |
| Interventions | EPO906, celecoxib |
| Enrollment | 75 |
| Start date | Oct 1, 2004 |
| Primary completion | Dec 1, 2016 |
| Completion | Dec 1, 2017 |
| First posted | Sep 12, 2005 |
| Last update posted | Jun 27, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: